Tonix in the News :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Aug 21, 2025

Cort Johnson, the founder and director of Health Rising speaks with Seth Lederman, M.D. about the approval of Tonmya™, the new FDA-approved drug for the treatment of fibromyalgia

Tip Ranks | Aug 15, 2025

Tonix Pharma Gains FDA Approval for Tonmya

Tip Ranks | Aug 15, 2025

Tonix announces FDA approval of Tonmya for treatment of fibromyalgia

Seeking Alpha | Aug 15, 2025

Tonix wins FDA approval of fibromyalgia drug Tonmya

Guru Focus | Aug 15, 2025

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia | TNXP Stock News

Investing | Aug 15, 2025

FDA approves Tonix’s fibromyalgia treatment, first in 15 years

Stock Titan | Aug 15, 2025

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

HCP Live | Aug 15, 2025

FDA Approves TNX-102 SL, First New Fibromyalgia Therapy in 15 Years

Reuters | Aug 15, 2025

US FDA approves Tonix Pharma's drug to manage pain related to chronic condition

BIOCENTURY Danielle Golovin, Senior Biopharma Analyst | Jun 23, 2025

Fibromyalgia drug nearing approval after a 16-year lull

ASM.org | Nov 13, 2024

Potential Single-Dose Smallpox and Mpox Vaccine Advances

mSphere | Nov 13, 2024

Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models

Fierce Pharma | Sep 19, 2024

New migraine drugs less effective than previous generation of triptan meds: BMJ study

Chemical & Engineering News | Sep 18, 2024

R&D for long COVID is collapsing

The National News | Sep 1, 2024

Big Pharma treating mpox as African problem puts global population at risk

DailyMail | Aug 3, 2024

New 'lethal' mpox variant is spreading 'unchecked', posing 'severe' risk to hundreds of thousands with one in ten children dying from disease after suffering fever, rashes and pus-filled blisters, experts warn

PharmaVoice | Aug 28, 2023

Why pharma isn’t done tackling migraines

STAT | Apr 20, 2023

The NIH has poured $1 billion into long Covid research — with little to show for it

BioSpace | Apr 13, 2023

Treatment Approach to Depression Sees Paradigm Shift

Inside Health Policy | Sep 29, 2022

Executive Order Could Lead To Big Subsidies For Domestic Biopharmaceutical Manufacturing